Hyperpigmented Skin? Why Tranexamic Acid Is The Ingredient To Know
It wasn't long ago that tranexamic acid was the reserve of medicine. Wielded by doctors for its blood clotting properties, it was found effective at halting hemorrhages, and is still used as an intervention in bleeding symptoms today. But a fortuitous mistake ushered the ingredient into mainstream skincare when a patient prescribed oral tranexamic acid experienced skin lightening as a side effect.
Now, tranexamic acid (also denoted by TXA) can be found over the counter and almost everywhere you look. As a beauty editor with skin prone to hyperpigmentation, tranexamic acid serums have been a saving grace. To find out how tranexamic acid works so well, I asked experts for a full breakdown. Ahead, you'll find everything you need to know about the ingredient, from the ideal concentration to all the best tranexamic acid products to use.
Debbie Thomas is a skin and laser expert, VIP facialist and the founder of Clinic.
is a skin and laser expert, VIP facialist and the founder of Clinic. Dr Tatyana Lapa-Wright is an aesthetic doctor and the owner of Hardwick Clinic.
What is tranexamic acid?
'Tranexamic acid is a synthetic derivative of the amino acid lysine,' Dr. Lapa-Wright informs Vogue. It's not an acid in the conventional sense—it does not have exfoliating properties. But it does have brightening benefits on the skin. According to Thomas, tranexamic acid is used topically for treating pigmentation and inflammatory redness. 'It effectively reduces excess melanin production without bleaching or stripping the skin and is ideal for melasma, post-inflammatory pigmentation, and redness-prone skin.'
How does tranexamic acid work on skin?
Oral tranexamic acid is a controlled medicine, typically prescribed to help with menstrual symptoms or nosebleeds, though some dermatologists may prescribe the pills for melasma patients. Whether oral or topical, TXA works by inhibiting tyrosinase (an enzyme that triggers pigment production) to reduce the appearance of dark patches. Studies have shown that tranexamic acid can also reduce inflammation, which makes it helpful in the prevention and reduction of post-inflammatory hyperpigmentation (PIH). Both of our experts add that TXA strengthens the skin barrier, evens skin tone, and can soothe redness when used as part of a dedicated routine.
How to use tranexamic acid for hyperpigmentation:
'Apply tranexamic acid once daily (evening preferred), after cleansing and before moisturizer,' Thomas instructs. 'Avoid layering with strong acids or retinoids initially—use it on its own for two to three weeks before introducing other actives.' Per Dr. Lapa-Wright, beginners should start low and go slow, as TXA can be irritating on sensitive skin. And don't skip the sun protection, which Thomas says will protect your results: 'Use a broad spectrum SPF, and if it is tinted, even better.'
How long does it take for tranexamic acid to work?
Timelines given by our experts vary, but both agree that tranexamic acid offers 'gradual results, not overnight miracles.' On average, you can expect to notice visible improvements in 8 to 16 weeks with consistent use.
What to look for in an effective tranexamic acid formula
Optimal concentration : According to Thomas, effective tranexamic acid formulas will have TXA listed within the top half of the ingredients list, ideally at a 2 to 5% concentration. 'Higher isn't always better,' Dr. Lapa-Wright notes.
: According to Thomas, effective tranexamic acid formulas will have TXA listed within the top half of the ingredients list, ideally at a 2 to 5% concentration. 'Higher isn't always better,' Dr. Lapa-Wright notes. Additional ingredients: Both experts recommend looking for TXA paired with complementary actives such as niacinamide, azelaic acid, and liquorice root, which safely enhance its effects. 'Avoid irritants like alcohol and fragrances, especially for sensitive skin.'
Both experts recommend looking for TXA paired with complementary actives such as niacinamide, azelaic acid, and liquorice root, which safely enhance its effects. 'Avoid irritants like alcohol and fragrances, especially for sensitive skin.' Protective packaging: Per Thomas, look for airtight, opaque packaging that protects ingredient stability.
Now you know what to look for and how best to introduce tranexamic acid into your skincare routine, you can try using the ingredient to get closer to your clear skin goals.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
43 minutes ago
- Forbes
Secretary Of HHS Kennedy Fires Entire CDC's Vaccine Advisory Committee
Secretary of Health and Human Services, Robert F. Kennedy Jr., is making good on his promise to radically reshape the vaccine policy landscape as he ousts the entire Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. In a press release issued by the Department of HHS on June 9th, Kennedy says he's doing this in order to restore the public's trust in vaccine science in America. It's unknown who Kennedy will hire to replace committee members, but it's possible they may share his skeptical views of vaccines. In turn, this could have the effect of increasing the public's vaccine hesitancy. ACIP advises the director of the CDC on which vaccines approved by the Food and Drug Administration should be used; for example, recommending which groups of people ought to be vaccinated, at what doses and when. ACIP's guidance is not binding, though CDC almost always follows it and provides recommendations to the public on what is to be included in the United States adult and childhood immunization schedules. Neither the Secretary of HHS nor the CDC director can unilaterally ban vaccines. But they can alter the CDC's messaging, fire and hire ACIP committee members and revise vaccination scheduling. Moreover, the Secretary of HHS together with heads of agencies under his oversight can pursue changes in guidance that restructure regulatory pathways for vaccine development and revise recommendations to the public on who should get vaccinated. In a major policy shift last month, Food and Drug Administration officials proposed requiring new clinical trial research with respect to the effectiveness of COVID-19 vaccines in healthy people under 65, including pregnant women, before issuing an updated approval for a broader population. And we observed a preview of the new FDA approach when the agency made an unusual decision in May to limit the approval of the nation's only non-mRNA coronavirus vaccine, Novavax's nuvaxovid, for use only in adults 65 and older or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19. And on May 31st, Moderna won approval for its latest COVID-19 vaccine with a similar set of limits. To be indicated for a broader population, the FDA plans to require that vaccine makers conduct booster trials to demonstrate effectiveness in people under 65 or without certain risks. These trials could take a year to complete, according to a STAT report. As such, it's not something that can be accomplished prior to the autumn, even if Novavax, Pfizer, or Moderna, wished to pursue this pathway. Changes are also occurring at CDC in terms of its messaging on vaccines. While all the standard childhood and adult vaccines are still on the website, the messaging in some instances incorporates more of an 'informed consent' approach than a recommendation. Informed consent is the principle that people should be notified of all the risks, as well as benefits, of any medical intervention they receive or any therapeutic they are prescribed. All of the changes we're seeing shouldn't come as a surprise. Kennedy's vaccine-skeptic views are well-known. And while he told the podcaster Lex Fridman in 2023 that some vaccines 'are probably averting more problems than they're causing,' he also maintained that 'there's no vaccine that is, you know, safe and effective.' In March, he commissioned a large-scale study to investigate debunked theories that link autism to the measles, mumps and rubella vaccine. And, amid an outbreak of measles this year that started in Texas and spread to surrounding states and cost the lives of three people, Kennedy appeared at times to downplay its severity. Kennedy has also been outspoken about the existing organizational framework within his department, in which he says that with respect to vaccines there are conflicts of interest. In announcing today's purge of the entire ACIP committee, Kennedy cited the pharmaceutical industry's close relationship with government agencies and ACIP that advises them. But it's unclear what Kennedy means when current ACIP members include academics, a chief medical officer of a community health center, a state public health higher-up and the owner of a family medicine practice. Kennedy defends himself as merely wanting placebo-controlled trials prior to licensure and no more strict vaccine mandates. However, the vaccines he criticizes are typically subject to such clinical trials. Furthermore, arguably the mandates Kennedy opposes, which have been in place since the 1960s, have helped to contribute to a dramatic decline in childhood infectious diseases. From smallpox inoculations—which began in the late 18th century and ended when the disease was eradicated in the 1970s—to mumps, rubella, tetanus, diphtheria, polio and measles immunizations, vaccinations have saved millions of lives and prevented crippling and life-threatening illnesses from occurring. To illustrate, mass vaccination programs with single or combination—measles, mumps and rubella—shots began in the 1960s and quickly suppressed the spread of measles in most developed countries. The measles vaccine is 'sterilizing,' which means it not only prevents illness, but also transmission. The American public is already increasingly vaccine-hesitant around standard childhood immunizations. This is likely to lead to more outbreaks and preventable severe illness and death. Should Kennedy appoint like-minded vaccine skeptics to the ACIP committee, that could undermine the public's trust in vaccines even further.


CBS News
an hour ago
- CBS News
Minnesota Legislature votes to remove undocumented immigrant adults from state health program
A contentious proposal that will remove undocumented immigrant adults from a state health care coverage program cleared the Minnesota Legislature on Monday — a key part of the compromise in the divided Capitol to pass the next two-year state budget. The measure makes undocumented adults no longer eligible for MinnesotaCare by the end of this year, just months after the DFL priority took effect in January. It's on its way to Gov. Tim Walz's desk, and he's expected to sign it. There is a provision in another proposal that will withhold funding for the health department if he doesn't. The change was a sticking point during negotiations between Democrats and Republicans, for whom repealing that law was a top priority in the divided Legislature. GOP lawmakers are concerned about growing enrollment and the cost to the state in future years. "If California and Illinois can't make the numbers work, what makes us think Minnesota can? The question before us is simple: Will we continue down a path of fiscal recklessness or will we act now to protect Minnesota taxpayers," said Rep. Harry Niska, R-Ramsey. Meanwhile, the bill sparked fierce pushback and emotional testimony from DFL lawmakers who said the change will cause irreparable harm. Former DFL House Speaker Melissa Hortman, who negotiated the budget deal, was the sole Democrat to vote for it in the tied House chamber-despite her personal opposition-clearing the way for its passage. "This bill is cruel. It is inhumane. And it will cost real human, Minnesotan lives," said Rep. Jamie Long, DFL-Minneapolis. More than 20,000 undocumented immigrants are enrolled in MinnesotaCare, which is more than expected for the first four months of the year, and 24% of them are children under 18, according to data from the Minnesota Department of Human Services. The cost to the state is slightly more expensive than originally estimated for this period. From January through the end of April, paid claims totalled $3.9 million, DHS data showed, but a spokeswoman said it is too early to know if it would have been as costly in a few years as Republicans claimed. The House took up the bill first during the one-day special session that began Monday to wrap up the next two-year state budget, and debated it for four hours. There were demonstrators outside the chamber before they gaveled in Monday with signs that read, "health care cuts kill." The Senate followed suit later with all GOP votes plus four Democrats, including Senate Majority Leader Erin Murphy, DFL-St. Paul, who held back tears as she spoke about the bill. "We will regain coverage for people because we are compassionate people and that's what we do in Minnesota. I made an agreement. I gave my word. I will vote for this and it's among the most painful votes I've ever taken," she said. For three weeks, lawmakers worked largely behind closed doors to fine tune the bills that together will make up the roughly $66 billion state budget for the next two years. They gaveled in to begin on Monday for what they planned to be a one-day special session to end Tuesday morning. Passing the MinnesotaCare coverage rollback was the most contentious proposal on the to-do list, which includes 14 bills.

Wall Street Journal
an hour ago
- Wall Street Journal
RFK Jr. Removes All Members of CDC Vaccine Panel
WASHINGTON—Health Secretary Robert F. Kennedy Jr. removed all the members of a key committee that recommends vaccines, and when and how often adults and children should get them. Kennedy wrote Monday in a Wall Street Journal opinion article that he would do a 'clean sweep' of the panel's 17 members, all of whom were appointed during the administration of former President Joe Biden.